Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enliven Therapeutics (ELVN) Change in Acquisitions & Divestments (2020 - 2026)

Enliven Therapeutics has reported Change in Acquisitions & Divestments over the past 7 years, most recently at $108.4 million for Q1 2026.

  • Quarterly results put Change in Acquisitions & Divestments at $108.4 million for Q1 2026, up 78.6% from a year ago — trailing twelve months through Mar 2026 was $320.6 million (down 4.49% YoY), and the annual figure for FY2025 was $272.9 million, down 13.07%.
  • Change in Acquisitions & Divestments reached $108.4 million in Q1 2026 per ELVN's latest filing, up from $87.7 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $117.2 million in Q4 2024 and bottomed at -$12.0 million in Q3 2022.
  • Median Change in Acquisitions & Divestments over the past 5 years was $64.2 million (2025), compared with a mean of $58.2 million.
  • The largest annual shift saw Change in Acquisitions & Divestments tumbled 189.2% in 2022 before it soared 434.64% in 2023.
  • Over 5 years, Change in Acquisitions & Divestments stood at -$12.0 million in 2022, then skyrocketed by 769.29% to $80.0 million in 2023, then soared by 46.55% to $117.2 million in 2024, then decreased by 25.21% to $87.7 million in 2025, then rose by 23.58% to $108.4 million in 2026.
  • Business Quant data shows Change in Acquisitions & Divestments for ELVN at $108.4 million in Q1 2026, $87.7 million in Q4 2025, and $67.8 million in Q3 2025.